formosanin c has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Kong, AN; Li, P; Wen, X; Xin, Q; Yang, J; Ye, K; Zhang, B | 1 |
Fan, L; Li, Y; Mei, Q; Meng, J; Sun, Y; Yue, Z; Zhang, D; Zhang, F; Zhang, R; Zhang, X | 1 |
2 other study(ies) available for formosanin c and Colorectal Neoplasms
Article | Year |
---|---|
Paris Saponin II inhibits colorectal carcinogenesis by regulating mitochondrial fission and NF-κB pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Diosgenin; Female; HCT116 Cells; HT29 Cells; Humans; Mice, Nude; Mitochondrial Dynamics; NF-kappa B; Saponins | 2019 |
Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Colorectal Neoplasms; Diosgenin; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Neoplasm Metastasis; Saponins | 2015 |